SEC 13F Intelligence

Hussman Strategic Advisors, Inc. / STOK

Hussman Strategic Advisors, Inc.’s Stoke Therapeutics Inc Position

Does Hussman Strategic Advisors, Inc. own Stoke Therapeutics Inc (STOK)? Yes84.0K shares worth $3M (+0.59% of its 13F portfolio) as of Q1 2026, up from 63.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
84.0K
% of Portfolio
+0.59%
Quarters Held
2
currently held

Position History STOK

Reported value by quarter
Q4 ’25: $2MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202684.0K$3M+0.59%
Q4 202563.0K$2M+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hussman Strategic Advisors, Inc.’s full portfolio or all institutional holders of STOK.